CELEGENCE Blog ATMP Regulation in the EU and US: Global Convergence?

ATMP Regulation in the EU and US: Global Convergence? Advanced Therapy Medicinal Products (ATMPs) represent a breakthrough in modern medicine, offering new treatment potential for genetic disorders, cancer, and rare diseases. However, ensuring their safety and efficacy presents significant regulatory challenges. While the European Medicines Agency (EMA) and the US Food and DrugThe post ATMP Regulation in the EU and US: Global Convergence? appeared first on Celegence.